Cetuximab MMAE
Product Specifications
Target
Antibody-Drug Conjugates (ADCs) |||EGFR|||Microtubule Associated
Related Pathways
Angiogenesis|||Cytoskeletal Signaling|||JAK/STAT signaling|||Antibody-drug Conjugate/ADC Related|||Tyrosine Kinase/Adaptors
Bioactivity
Cetuximab-MMAE, an antibody-drug conjugate (ADC), combines an EGFR-targeting antibody with Monomethyl auristatin E (MMAE) to investigate colorectal and head and neck cancers.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
